IGC Pharma, Inc. - COM NEW (IGC)

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Number of holders
7
Total 13F shares, excl. options
383,188
Shares change
+217,889
Total reported value, excl. options
$215,000
Value change
+$118,091
Number of buys
3
Number of sells
1
Price
$0.5636

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2018

As of 31 Mar 2018 IGC Pharma, Inc. - COM NEW (IGC) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 383,188 shares of stock of the company.
Largest 8 holders included CITADEL ADVISORS LLC, Virtu Financial LLC, Creative Planning, SUNTRUST BANKS INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, ROYAL BANK OF CANADA, LADENBURG THALMANN FINANCIAL SERVICES INC., and THOMPSON DAVIS & CO., INC..
This table shows 8 institutional shareholders of the security as of 31 Mar 2018.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.